G GSK PLC
| Market Cap | $113.29B |
| P/E Ratio | 15.45 |
| Forward P/E | 11.04 |
| Dividend Yield | 3.15% |
| Beta | 0.35 |
| 52W Range | $32.31 - $60.69 |
| # Hedge Funds | 6 |
| Sector | Healthcare |
| Industry | Drug Manufacturers - General |
Hedge Fund Ownership
| Investor 6 | % of Portfolio Weight of this stock in the investor's portfolio | Value Total dollar value of the position | Shares Number of shares held | Activity Portfolio change type: New, Increased, Decreased, or Sold |
|---|---|---|---|---|
| Hillman Value Fund Hillman Capital Management | 3.53% | $5.61M | 114,336 | Reduce 19.36% |
| Dodge & Cox Dodge & Cox | 1.81% | $3.36B | 68,517,969 | Reduce 12.61% |
| Kahn Brothers Group Kahn Brothers Group | 1.55% | $8.76M | 178,696 | Reduce 31.49% |
| Tweedy Browne Co. Tweedy Browne Co LLC | 0.33% | $4.03M | 82,243 | — |
| Sarah Ketterer Causeway Capital Management | 0.02% | $1.66M | 33,897 | Reduce 97.12% |
| Richard Pzena Pzena Investment Management | 0.00% | $659.00K | 13,444 | Add 54.23% |
Frequently Asked Questions
What is GSK stock price today?
GSK PLC (GSK) is currently trading at $56.69. The stock has a 52-week range of $32.31 to $60.69 and a market capitalization of $113.29B.
Is GSK a good stock to buy in 2026?
GSK PLC has a P/E ratio of 15.4 (forward P/E: 11.0), a dividend yield of 3.15%, and 1-year performance of +51.1%. 6 hedge funds hold this stock. Review the fundamentals and ownership data above to make an informed decision.
Are insiders buying or selling GSK stock?
There have been 0 insider transactions for GSK in recent months. Insider buys can signal management confidence, while sales may reflect diversification or personal financial planning. Check the Insider Trading section above for details.
How has GSK stock performed over the past year?
GSK PLC (GSK) has returned +51.1% over the past 12 months. The stock traded between $32.31 and $60.69 during this period, and is currently at $56.69.
Which hedge funds own GSK (GSK PLC)?
6 tracked hedge funds currently hold GSK in their portfolios as of the latest 13F filings. See the ownership table above for the complete list.
What is GSK's market cap and valuation?
GSK PLC (GSK) has a market capitalization of $113.29B. The trailing P/E ratio is 15.4 and forward P/E is 11.0. The stock is classified in the Healthcare sector.
What is GSK's revenue and profitability?
GSK PLC reported revenue of $32.67B with net income of $5.72B and a profit margin of 0.17%. The stock has a beta of 0.35.
What sector is GSK in and who are its biggest institutional holders?
GSK PLC (GSK) operates in the Healthcare sector. It is held by 6 tracked hedge funds. See the ownership table above for the complete list.